{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:01:24Z","timestamp":1781517684247,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ejpb.2023.08.006","type":"journal-article","created":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T18:39:14Z","timestamp":1691865554000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Direct drug milling in organic PLGA solution facilitates the encapsulation of nanosized drug into PLGA microparticles"],"prefix":"10.1016","volume":"191","author":[{"given":"Chenghao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9188-3133","authenticated-orcid":false,"given":"Roland","family":"Bodmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2023.08.006_b0005","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1517\/17425247.2012.717926","article-title":"Recent advances in polymeric microspheres for parenteral drug delivery\u2014part 2","volume":"9","author":"Mao","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2023.08.006_b0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2019.05.003","article-title":"Injectable, long-acting PLGA formulations: analyzing PLGA and understanding microparticle formation","volume":"304","author":"Park","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2023.08.006_b0015","first-page":"1","article-title":"Meeting the unmet: from traditional to cutting-edge techniques for poly lactide and poly lactide-co-glycolide microparticle manufacturing","author":"Schoubben","year":"2019","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.ejpb.2023.08.006_b0020","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ijpharm.2016.01.020","article-title":"Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: state-of-the-art and challenges","volume":"499","author":"Ramazani","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2023.08.006_b0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0168-3659(91)90104-L","article-title":"Pseudoephedrine HCl microspheres formulated into an oral suspension dosage form","volume":"15","author":"Bodmeier","year":"1991","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2023.08.006_b0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0168-3659(00)00299-6","article-title":"Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres","volume":"69","author":"Freytag","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2023.08.006_b0035","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1023\/A:1016419303727","article-title":"The preparation and evaluation of drug-containing poly (dl-lactide) microspheres formed by the solvent evaporation method","volume":"4","author":"Bodmeier","year":"1987","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2023.08.006_b0040","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/10837459709022631","article-title":"Microencapsulation of Antimicrobial Ceftiofur Drugs","volume":"2","author":"Bodmeier","year":"1997","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejpb.2023.08.006_b0045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0939-6411(97)00125-2","article-title":"Biodegradable, somatostatin acetate containing microspheres prepared by various aqueous and non-aqueous solvent evaporation methods","volume":"45","author":"Herrmann","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2023.08.006_b0050","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijpharm.2008.04.042","article-title":"Principles of encapsulating hydrophobic drugs in PLA\/PLGA microparticles","volume":"364","author":"Wischke","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2023.08.006_b0055","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1023\/A:1015939600866","article-title":"Effect of drug (core) particle size on the dissolution of theophylline from microspheres made from low molecular weight cellulose acetate propionate","volume":"6","author":"Shukla","year":"1989","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2023.08.006_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122313","article-title":"A comparative study of PLGA microparticle properties loaded with micronized, nanosized or dissolved drug","volume":"628","author":"Zhang","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2023.08.006_b0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejpb.2017.02.021","article-title":"Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques","volume":"115","author":"Wang","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2023.08.006_b0070","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/02652040010019587","article-title":"The in-vitro and in-vivo characterization of PLGA: L-PLA microspheres containing dexamethasone sodium phosphate","volume":"18","author":"Ero\u011flu","year":"2001","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejpb.2023.08.006_b0075","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/02652040701233655","article-title":"Effect of poly(lactide-co-glycolide) molecular weight on the release of dexamethasone sodium phosphate from microparticles","volume":"24","author":"Jaraswekin","year":"2007","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejpb.2023.08.006_b0080","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejps.2016.03.012","article-title":"Optimising the controlled release of dexamethasone from a new generation of PLGA-based microspheres intended for intravitreal administration","volume":"92","author":"Rodr\u00edguez Villanueva","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2023.08.006_b0085","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijpharm.2012.09.034","article-title":"Drug nanocrystals in the commercial pharmaceutical development process","volume":"453","author":"M\u00f6schwitzer","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2023.08.006_b0090","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0378-5173(98)00380-9","article-title":"Development of 5-iodo-2\u2032-deoxyuridine milling process to reduce initial burst release from PLGA microparticles","volume":"178","author":"Geze","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2023.08.006_b0095","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/mi7120236","article-title":"Microfluidic fabrication of hydrocortisone nanocrystals coated with polymeric stabilisers","volume":"7","author":"Odetade","year":"2016","journal-title":"Micromachines"},{"key":"10.1016\/j.ejpb.2023.08.006_b0100","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1208\/s12249-017-0722-4","article-title":"Influence of drug brittleness, nanomilling time, and freeze-drying on the crystallinity of poorly water-soluble drugs and its implications for solubility enhancement","volume":"18","author":"Colombo","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2023.08.006_b0105","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevB.62.10548","article-title":"Size-dependent melting point depression of nanostructures: nanocalorimetric measurements","volume":"62","author":"Zhang","year":"2000","journal-title":"Phys. Rev. B"},{"key":"10.1016\/j.ejpb.2023.08.006_b0110","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1021\/acs.cgd.7b01664","article-title":"Using milling to explore physical states: the amorphous and polymorphic forms of dexamethasone","volume":"18","author":"Oliveira","year":"2018","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejpb.2023.08.006_b0115","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0378-5173(02)00326-5","article-title":"Comparative physicochemical properties of hydrocortisone\u2013PVP composites prepared using supercritical carbon dioxide by the GAS anti-solvent recrystallization process, by coprecipitation and by spray drying","volume":"245","author":"Corrigan","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2023.08.006_b0120","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/pharmaceutics12060594","article-title":"Chitosan derivatives with mucoadhesive and antimicrobial properties for simultaneous nanoencapsulation and extended ocular release formulations of dexamethasone and chloramphenicol drugs","volume":"12","author":"Karava","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2023.08.006_b0125","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ijpharm.2012.11.019","article-title":"PLA\/F68\/dexamethasone implants prepared by hot-melt extrusion for controlled release of anti-inflammatory drug to implantable medical devices: I. Preparation, characterization and hydrolytic degradation study","volume":"441","author":"Li","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2023.08.006_b0130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2019.01.012","article-title":"Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma","volume":"297","author":"Arranz-Romera","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2023.08.006_b0135","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jconrel.2016.03.011","article-title":"Seeing is believing, PLGA microsphere degradation revealed in PLGA microsphere\/PVA hydrogel composites","volume":"228","author":"Gu","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2023.08.006_b0140","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jconrel.2012.12.028","article-title":"Polymeric \u201csmart\u201d coatings to prevent foreign body response to implantable biosensors","volume":"169","author":"Wang","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2023.08.006_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119339","article-title":"The effect of PLGA molecular weight differences on risperidone release from microspheres","volume":"582","author":"Kohno","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2023.08.006_b0150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/02652040701233655","article-title":"Effect of poly (lactide-co-glycolide) molecular weight on the release of dexamethasone sodium phosphate from microparticles","volume":"24","author":"Jaraswekin","year":"2007","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejpb.2023.08.006_b0155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpharm.2007.10.030","article-title":"PLGA-based drug delivery systems: importance of the type of drug and device geometry","volume":"354","author":"Klose","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2023.08.006_b0160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.05.049","article-title":"The mechanisms of drug release in poly (lactic-co-glycolic acid)-based drug delivery systems\u2014a review","volume":"415","author":"Fredenberg","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2023.08.006_b0165","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"key":"10.1016\/j.ejpb.2023.08.006_b0170","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.biomaterials.2008.12.044","article-title":"Development of highly porous large PLGA microparticles for pulmonary drug delivery","volume":"30","author":"Yang","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2023.08.006_b0175","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijpharm.2016.08.032","article-title":"Towards a better understanding of the different release phases from PLGA microparticles: dexamethasone-loaded systems","volume":"514","author":"Gasmi","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2023.08.006_b0180","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11095-013-1166-5","article-title":"Microspheres prepared with PLGA blends for delivery of dexamethasone for implantable medical devices","volume":"31","author":"Wang","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2023.08.006_b0185","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijpharm.2006.11.061","article-title":"Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content","volume":"336","author":"Budhian","year":"2007","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641123002096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641123002096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:51:32Z","timestamp":1760547092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641123002096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":37,"alternative-id":["S0939641123002096"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.08.006","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct drug milling in organic PLGA solution facilitates the encapsulation of nanosized drug into PLGA microparticles","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}